Ignite Creation Date:
2024-05-06 @ 6:39 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05739981
Status:
RECRUITING
Last Update Posted:
2024-06-07
First Post:
2023-02-13
Brief Title:
Phase II IMNN-001 Also Known as GEN-1 on SLL With BEV and NACT Newly Diagnosed Advanced Ovarian Fallopian Tube or Primary Peritoneal Cancer
Sponsor:
Imunon
Organization:
Imunon
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-02-10
Start Date Type:
ACTUAL
Primary Completion Date:
2026-08-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-01-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-13
First Submit QC Date:
February 13 2023
Study First Post Date:
2023-02-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-08
Last Update Post Date:
2024-06-07
Last Update Post Date Type:
ACTUAL